Oncotype DX Genomic Testing for Madigan Army Medical Center, Washington
Closed Pre-Solicitation Posted
Not the latest version. See the latest pre-solicitation from .
- Solicitation number
- W81K0223Q0076
- Agency
-
Medical Command
Department of the Army, Department of Defense
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 621511 Medical Laboratories
- PSC
- Q301 Reference Laboratory Testing
- Place of performance
- Joint Base Lewis McChord, Washington 98431, United States
Notice details come from SAM.gov. Updated .
About this opportunity
This pre-solicitation notice seeks information to potentially award a firm fixed-price contract for Oncotype DX genomic testing services for the Department of Pathology at Madigan Army Medical Center in Tacoma, Washington. The Medical Readiness Contracting Office-Pacific of the Department of the Army Medical Command intends to acquire these commercial laboratory testing services, which will include Oncotype DX genomic testing, to support Madigan Army Medical Center. Interested parties must submit their capabilities and qualifications to perform this effort in writing no later than April 21, 2023 at 10:00 AM Hawaii Standard Time.
There is no set-aside designation specified. The NAICS code is 621511 for medical laboratories with a size standard of $41.5 million. Respondents must be registered in the System for Award Management with NAICS code 621511. The notice does not specify incumbent contractors or estimate contract values. The laboratory testing services will support an indefinite quantity for the Department of Pathology at Madigan Army Medical Center.
Notice text
This is a Sources Sought Notice. This is NOT a solicitation for proposals, proposal abstracts or quotations. The purpose of this notice is to obtain information regarding the availability and capability of qualified sources and whether or not to conduct this procurement on a competitive basis. The NAICS code is 621511 and the size standard is $41.5M. Your responses to the information requested will assist the Government in determining the appropriate acquisition method.
The Government intends to award a Firm Fixed-Price contract to the successful offeror. Madigan Army Medical Center (MAMC) has a requirement for Oncotype DX Genomic Testing Services for the Department of Pathology at MAMC, Tacoma, WA. The Contractor will provide personnel, management, transportation, labor, supplies, and equipment necessary to provide genetic cancer assays to support MAMC. The laboratory testing services to be provided shall include, but not be limited to Oncotype DX Genomic testing. 100% performance of work will be completed off post/base.
The Medical Readiness Contracting Office-Pacific intends to acquire a commercial item using FAR Part 12. This procurement is being conducted under FAR Part 13 Simplified Acquisition Procedures. Interested organizations may submit their capabilities and qualifications to perform the effort in writing no later than 21 APR 2023 at 10:00 AM Hawaii Standard Time. A determination by the Government not to compete this proposed effort on a full and open competition basis, based upon responses to this notice, is solely within the discretion of the Government.
Vendors are invited to submit information demonstrating their ability to fulfill the requirement in the form of a capability response that addresses the specific requirement identified in this notice. Responses to this notice should include company name, address, telephone number, point of contact (POC), and brochures which will allow the Government to understand your offerings and options. Capability statements should be submitted to the attention of Deborah.n.wada.civ@health.mil, Contract Specialist, Medical Readiness Contracting Office - Pacific. Telephone responses will not be accepted.
All vendors providing to the Federal Government are required to be registered in the System for Award Management (SAM) registry with NAICS code 621511.
Disclaimer and Important Notes: This notice does not obligate the Government to award a contract or otherwise pay for the information provided in response. Any organization responding to this notice should ensure that its response is complete and sufficiently detailed to allow the Government to determine the organization's qualifications to provide the required services. Respondents are advised that the Government is under no obligation to acknowledge receipt of the information received or
provide feedback to respondents with respect to any information submitted. No proprietary, classified, confidential or sensitive information should be included in your response.
Notice history
| Notice | Type | Posted |
|---|---|---|
| Oncotype DX Genomic Testing for Madigan Army Medical Center, WA | Pre-Solicitation | |
| This notice | Pre-Solicitation |
Similar open opportunities
| Opportunity | Agency | Set-aside | Responses due |
|---|---|---|---|
| NWI Offsite Pathology Services | Veterans Integrated Service Network 23 | Total Small Business | |
| Q301--Reference Laboratory Testing | Veterans Integrated Service Network 2 | No set-aside | |
| Laboratory Support Services | Washington Headquarters Service | No set-aside | |
| Q301--Notice of Intent to Sole Source - Pathology Reference Lab Services - 528,528A8 | Veterans Integrated Service Network 2 | No set-aside | |
| 6550--Cepheid GeneXpert Testing Supplies | Veterans Integrated Service Network 5 | No set-aside |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity